- cafead   Feb 28, 2023 at 10:42: PM
via In 2026—the first year Medicare’s price negotiations are set to start under the IRA—the top drugs expected to fall victim to discussions include blood thinners Eliquis from Bristol Myers Squibb and Xarelto from Johnson & Johnson. Oral diabetes drugs such as Merck's Januvia and Boehringer Ingelheim and Eli Lilly's Jardiance may also face negotiations during the first year, the journal says.
article source
article source